Business Context and Reporting Period
This Form 8-K was filed by JATT Acquisition Corp (not Zura Bio Ltd) on August 5, 2021. The registrant is a Cayman Islands-based Special Purpose Acquisition Company (SPAC) and an emerging growth company. The filing reports the entry into material definitive agreements on the date of the report.
Key Financial Metrics and Transaction Details
The filing details a specific capital raise transaction rather than standard operating financial metrics (revenue, profit, or cash flow from operations are not applicable as the company is pre-business combination).
- Transaction Type: Forward Purchase Agreements.
- Counterparties: Athanor Master Fund LP and Athanor International Master Fund, LP.
- Shares Issued: 7,500,000 Forward Purchase Shares (Class A ordinary shares).
- Purchase Price: $10.00 per share.
- Total Aggregate Proceeds: $75,000,000.
- Liquidity Impact: Funds are to be wired into escrow at least three business days prior to the closing of the initial business combination.
Material Changes and Agreements
The primary material change is the execution of the Forward Purchase Agreements, which secure $75 million in committed capital contingent upon the closing of the Company's initial business combination.
- Closing Timing: The sale of shares closes concurrently with the initial business combination.
- Restrictions: Shares are restricted securities until registered with the SEC and are subject to a lock-up agreement tied to the Company's sponsor, JATT Ventures, L.P.
- Trust Account Rights: Purchasers have no claim to monies in the trust account except for standard redemption and liquidation rights regarding public shares they may hold.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, revenue outlook, or management commentary on future performance beyond the terms of the agreement.
- Contingencies: The transaction is conditional on the closing of the initial business combination.
- Registration Rights: Holders are entitled to registration rights pursuant to an agreement applicable to private placement securities issued at the business combination closing.
- Unusual Items: The filing notes that the full text of the agreements will be included as exhibits to the next Form 10-Q.
Investor Verification Checklist
- Verify the identity of the registrant (JATT Acquisition Corp) versus the requested company name (Zura Bio Ltd).
- Confirm the status of the initial business combination to determine if the $75 million forward purchase will close.
- Review the upcoming Form 10-Q for the full text of Exhibits 10.1 and 10.2 (Forward Purchase Agreements).
- Check for any lock-up expiration dates associated with JATT Ventures, L.P. to understand share liquidity timelines.